Home » FDA Conducting Safety Review of Bristol-Myers Antibiotic
FDA Conducting Safety Review of Bristol-Myers Antibiotic
The Food and Drug Administration said Wednesday it’s conducting a safety review of Maxipime, a Bristol-Myers Squibb Co. antibiotic, after a study in a medical journal suggested the drug might be linked to an increased risk of death.
CNN Money
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May